Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-esketamine for Postoperative Sleep Disturbances
NCT06859892Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Mar 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in Postoperative sleep disturbance (PSD), sponsored by Peking University First Hospital. Started Mar 2025; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT06859892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06859892.